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Abstract
HCV is a leading cause of hepatocellular carcinoma and cirrhosis all over the world. Claudins belong to family of
tight junction’s proteins that are responsible for establishing barriers for controlling the flow of molecules around
cells. For therapeutic strategies, regulation of viral entry into the host cells holds a lot of promise. During HCV
infection claudin-1 is highly expressed in liver and believed to be associated with HCV virus entry after HCV
binding with or without co-receptor CD81. The claudin-1 assembly with tight junctions is regulated by post
translational modifications. During claudins assembly and disassembly with tight junctions, phosphorylation is
required at C-terminal tail. In cellular proteins, interplay between phosphorylation and O-b-GlcNAc modification is
believed to be functional switch, but it is very difficult to monitor these functional and vibrant changes in vivo.
Netphos 2.0 and Disphos 1.3 programs were used for potential phosphorylation; NetPhosK 1.0 and KinasePhos for
kinase prediction; and YinOYang 1.2 and OGPET to predict possible O-glycosylation sites. We also identified Yin
Yang sites that may have potential for O-b-GlcNAc and phosphorylation interplay at same Ser/Thr residues. We for
the first time proposed that alternate phosphorylation and O-b-GlcNAc modification on Ser 192, Ser 205, Ser 206;
and Thr 191 may provide an on/off switch to regulate assembly of claudin-1 at tight junctions. In addition these
phosphorylation sites may be targeted by novel chemotherapeutic agents to prevent phosphorylation lead by HCV
viral entry complex.
Introduction
HCV, the deadly virus has infected almost 3% of the
world population. Most of the infected patients develop
chronic infection leading to end stage hepatocellular
carcinoma. A better understanding of mechanism of
infection and the potential host co-factors facilitating its
replication is an urgent need of the hour for the release
of disease burden and vaccine development [1-3].
In multicellular organisms, movement of ions, proteins
and water is controlled by barriers known as tight junc-
tions (TJs) formed by epithelial and endothelial cell
monolayers [4]. While tight junctions require the coor-
dinated activity of several different proteins, the specifi-
city of tight junction’s permeability is regulated by
transmembrane proteins known as claudins [5]. Entry of
HCV in to the hepatocytes is a complex process and
involves interaction of HCV glycoproteins E1 and E2
with host receptor CD81 and scavenger receptor class B
m e m b e rI( S R - B I ) .I ti sr e p o r t e dt h a tt h e s et w or e c e p -
tors are not sufficient for its entry and later another
receptor claudin-1 was discovered which play an impor-
tant role in viral entry lately after viral binding to the
CD81 [6,7]. Claudins are transmembrane proteins which
play important role in tight junction formation and act
as barrier in cellular permeability. Tight junctions are
the combination of transmembrane and peripheral pro-
teins tied with cytoskeleton. Several classes of claudin
interact with other proteins to form tight junction and
regulate permeability of TJs. It is also observed that the
expression of claudin proteins found to be differentially
regulated in several cancers. Claudin-1 expression was
observed up-regulated in liver, stomach, thyroid, pan-
creas and cervix tumor formations [8-12]. Claudin-1
removal in mouse epidermis results in dramatic trans-
epidermal water loss, inferring its indispensable role in
creating and maintaining the epidermal barrier [13].
In biological systems, protein localization, activity,
their interaction with other proteins and overall
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tions (PTMs) [14]. Several PTMs like phosphorylation,
glycosylation, acetylation and methylation are some well
known examples. Phosphorylation in claudin protein
family is well observed and believed to be modulating
TJs permeability on both charged and uncharged ligands
and molecules [9,15]. Several enzymes like protein
kinase A (PKA), protein kinase C (PKC), protein phos-
phatase 2A (PP2A), MAPK etc are involved during clau-
din phosphorylation [16-18]. Phosphorylation has dual
effect on TJs functionality i.e. phosphorylation on some
claudins increased paracellular permeability or enhanced
barrier function [19]. It is reported that claudin-1 phos-
phorylation enhances its barrier functions while depho-
sphorylation leads to detergent solubility and enhanced
paracellular permeability [20].
O-glycosylation is also very important PTM of nuclear
and cytoplasmic proteins. During O-glycosylation one
molecule of N-acetylglucosamine (O-GlcNAc) is intro-
duced on Ser or Thr residue by enzyme OGT (O-
GlcNAc transferase). Addition of O-b-GlcNAc can inhi-
bit phosphorylation on Ser or Thr residue. Interplay
between O-b-GlcNAc modification and phosphorylation
on the same amino acid residues has been observed in
several nuclear and cytoplasmic proteins [21]. These
PTMs are dynamic and result in temporary conforma-
tional changes and regulate many functions of the pro-
teins. The interchange of these two modifications on the
same or neighboring residue may modulate the specific
function of the proteins either by enhancing or inhibit-
ing the functional capacity. Residues where O-b-GlcNAc
and phosphorylation compete for each other are known
as Yin Yang sites [22]. These Yin Yang sites can be pre-
dicted and analyzed using various computer-assisted
neural network-based programs, which can help us to
determine proteins regulatory functions by accessing
their modification potentials. The present work describe
potential phosphorylation, O-glycosylation and their
possible interplay sites which may influence claudin-1
interaction with TJs and their possible effects on HCV
entry and future therapeutics.
Materials and methods
The FASTA sequence of human claudin-1 was retrieved
from the SWISS-PROT sequence database [23] with
entry name CLD1_human. The primary accession num-
ber for this sequence was O95832. Homology search
w a sm a d eu s i n gt h eB L A S Ta tN C B Id a t a b a s ew i t h
default parameters [24]. The search was made for all
organisms’ sequences. A total of 250 hits were retrieved
for claudin-1 with highest bits score and zero expected
values. Out of 70 retrieved sequences, seven were
selected representing major mammalian or vertebrate
groups. The accession numbers for eight selected
sequences (Table 1) were O95832 (Human), Q6L708
(Bovine), D6RU0 (Sheep), C3VMK8 (Pig), O88551
(Mouse), P56745 (Rat), Q5ZMG2 (Chick) and Q5FW44
(Xentr). ClustalW [25] was used for multiple alignments
of all the sequences of claudin-1 to get the conservation
status.
The claudin-1 sequence used in this study was “MAN-
AGLQLLGFILAFLGWIGAIVSTALPQWRIYSYAGDNI
VTAQAMYEGLWMSCVSQSTGQIQCKVFDSLLNLS
STLQATRALMVVGILLGVIAIFVATVGMKCMKCLED
DEVQKMRMAVIGGAIFLLAGLAILVATAWYGNRIV
QEFYDPMTPVNARYEFGQALFTGWAAASLCLLGG
ALLCCSCPRKTTSYPTPRPYPKPAPSSGKDYV”.
Post-translational modifications prediction methods
We used more than one bioinformatics tools to access
the post-translational modification on claudin-1 to get
best results.
Prediction of phosphorylation residues and related kinases
Phosphorylation potential for human claudin-1 was pre-
dicted by using NetPhos 2.0 [26] and Disphos 1.3 server
[27]. These are neural network-based programs that pre-
dict the potential phosphorylation sites for each Thr, Ser
and Tyr residues. The minimum threshold value used to
predict phosphorylation is 0.5 for NetPhos 2.0.
Kinase specific phosphorylation sites in human clau-
din-1 were predicted by NetPhosK 1.0 [28] and Kinase-
Phos 2.0 server [29]. These servers predict the kinase
specific acceptor substrates including Ser, Thr and Tyr.
For the evaluation of experimentally verified phos-
phorylation sites on human claudin-1, Phospho.ELM
database was used [30]. This database contains a collec-
tion of experimentally confirmed Ser, Thr and Tyr resi-
dues in eukaryotic proteins.
Table 1 Different claudin-1 proteins used for multiple
alignment
Species
name
Universal
name
Accession
no.
Identity Score E-Value
Homo sapiens Human O95832 100% - -
Bos tauurus Bovine Q6L708 92.0% 1,053 1.0 × 10-
113
Ovis aries Sheep D6R6U0 91.0% 1,049 1.0 × 10-
112
Sus scrofa Pig C3VMK8 92.0% 1,018 1.0 × 10-
109
Mus musculus Mouse O88551 90.0% 1,025 1.0 × 10-
109
Rattus
novergicus
Rat P56745 91.0% 1,030 1.0 × 10-
110
Gallus gallus Chick Q5ZMG2 74.0% 875 3.0 × 10-
92
Xenopus
tropicalis
Xentr Q5FW44 67.0% 800 1.0 × 10-
83
Ahmad et al. Virology Journal 2011, 8:229
http://www.virologyj.com/content/8/1/229
Page 2 of 8Prediction of o-glycosylated residues and Yin Yang sites
O-b-GlcNAc modification potential sites were predicted
by YinOYang 1.2 [31-34] and OGPET [35]. YinOYang
1.2 program can predict the potential phosphorylation
sites as well and hence predict the Yin Yang sites with
highly uneven threshold that is adjusted in accordance
with amino acid surface accessibility. The potential Yin
Yang sites can also be predicted using this method.
Protein structure analysis
As there is no template model of claudin-1 available in
protein data bank [36], we designed an ab-initio model
by using software I-TASSER [37]. Data in sequence
form was uploaded to the server. Model with high C-
score was selected as ab-initio model. To view and ana-
lyze 3D structure Jmol [38] and PYmol [39] programs
w e r eu s e d .T oa s s e s s ,w h e t h e rt h ep r e d i c t e dS e ra n d
Thr residues have surface accessibility for post-transla-
tional modifications, NetSurfP was used [40].
Neural networks-based prediction methods
All the methods used for predicting post translational
modifications like ANNs (artificial neural networks) or
SVM (support vector machine) etc have been extensively
used in biological sequence study and predicting the
possible potentials for PTMs [41]. The methods devel-
oped using machine learning approach includes memor-
izing the neural networks with the sequence
environment windows of phosphorylated/glycosylated
and non-phosphorylated/non-glycosylated sites. The
input data of phosphorylated/glycosylated and non-
phosphorylated/non-glycosylated sites is presented to
the neural networks in the form of binary codes of 21
digits. A threshold value in the form of bits is set for
positive hit and zero for negative hits. The learning pro-
cess and performance is checked with the data reserved
for cross validation using statistical equations. During
learning, the error is computed and weights given to
each neuron are set to get the maximum correct predic-
tions. It helps in reducing the error and hence decreas-
ing the false positive and false negative prediction sites.
Results
Alignment of sequences for the determination of
conserved status of Ser/Thr residues within claudin-1
Human claudin-1 was aligned with other species. Con-
served and semi-conserved substituted Ser and Thr residues
within each subtype were determined (Figure 1). It is clear
from figure that Ser 34, 53, 58, 69, 185 and 192; and Thr
42, 59, 80, 153 and 191 are highly conserved in vertebrates.
Meanwhile, Ser 24, 56, 75, 173, 205 and 206; and Thr 25,
76, 99, 167, 190 and 195 are conserved in mammals.
Acquiring experimentally verified S/T/Y residues
Data for experimentally confirmed S/T/Y residues was
obtained from Phospho.ELM and UniprotKB http://
www.uniprot.org. Human claudin-1 has three phosphor-
ylation sites Tyr 203, Ser 205 and Ser 206 by similarity
with Mus musculus.
Prediction of Phosphorylation Sites
For the prediction of possible Ser and Thr residues for
potential phosphorylation, NetPhos 2.0 server was used. A
total of 7 sites showed high potential for phosphorylation.
Amongst these 3 were Ser, 3 Thr and 1 was Tyr. All these
7 predicted sites were highly conserved in mammals (Fig-
ure 2A). Ser 58, Thr 99 and Thr 190 showed probable
potential for phosphorylation. On the other hand DisPhos
1.3 predicts Thr 191, 195 and Ser 205, 206 for high and
Ser 192 for probable phosphorylation potential.
Prediction of Kinases involved in Phosphorylation
A number of kinases may be implicated for phosphory-
lation of Ser and Thr residues. Almost each kinase pre-
dicted is involved in phosphorylation of two or more
residues. The predicted kinases involved in phosphoryla-
tion of claudin-1 by NetPhos K, KinasePhos are shown
in Table 2.
Prediction of O-linked glycosylation sites
Prediction results for O-linked glycosylation sites
showed that claudin-1 has potential for O-b-GlcNAc
modification (Figure 2B). YinOYang 1.2 predicted 4
potential sites for O-b-GlcNAc modification including
Ser 192, 205 and 206; and Thr 191. All these sites were
highly conserved in vertebrates. Ser 206 was replaced by
Thr in chick. OGPET predicts Ser 56, 205, 206 and Thr
42, 59, 153, 167, 195 for high O-glycosylation potential.
Identification of False-Negative Sites
The Ser and Thr residues which were not predicted to
be O-b-GlcNAc modified but showed very high potential
for phosphorylation and were close to threshold value
are known as false-negative sites (FN-sites). A list of Yin
Yang and FN-Yin Yang residues is given in Table 3.
Two residues Thr 153 and Thr 195 was predicted as
FN-residue. Thr 153 was highly conserved in vertebrates
while Thr 195 was conserved in mammals (Figure 1).
Potential Yin Yang sites for claudin-1
For the interplay of phosphorylation and O-b-GlcNAc
modification, five possible Yin Yang sites were proposed
(Figure 2C). These Yin Yang sites are proposed on the
basis of conservation status of Ser/Thr residues in clau-
din-1. The Ser/Thr residues are also proposed for the
possible interplay of phosphorylation and O-b-GlcNAc
modification on the basis of their similarity with other
species. These Ser/Thr residues which are predicted “by
similarity” are not yet experimentally known in human
but these are known in other species of vertebrates.
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Among vertebrates claudin-1 has highly conserved
globular domain while, less conserved N- and C-term-
inals. Claudin-1 also showed highly conserved status
among mammals (Figure 1). The claudin tails espe-
cially C-terminal is believed to be post-translationally
modified [9,16,42]. The C and N- terminals of claudin
associate with a number of proteins like multi-PDZ
protein MUPP1, Pals1 and Zonula occludens proteins
1 ,2a n d3[ 4 3 ] .E v a n set al. (2007) found that claudin-
1 was necessary for HCV entry after its binding with
CD81 receptors. Recent findings showed that claudin-1
can enable cell to cell transfer of HCV [7] and the C-
terminal of claudin is related to protein stability, alter-
ing protein turnover and therefore the paracellular per-
meability [44].
It is interesting to note that the post translational
modifications regulate the TJ proteins functions. How-
ever little data is available. Phosphorylation of claudin is
reported to be linked with permeability modulation of
TJs [9,44]. Claudin-4 is phosphorylated on Ser-194, Thr-
189, claudin-3 at Thr-192, claudin-16 at Ser-217, clau-
din-5 at Thr-205 and Thr-207 [45-54]. In most claudins,
phosphorylation at C-terminal disrupts the functions of
TJs in many cancers. It is already reported that in HCV,
claudin-1 expression was high as compared to other
Table 2 Predicted phosphorylation and O-glycosylation sites on Claudin-1 protein
Substrate Position Phosphorylation prediction Kinase prediction O-glycosylation prediction Surface accessibility
Netphos Disphos NetphosK Kinasephos YinOYang OGPET NetSurfP
Ser 24 N N - - N HP B
Thr 25 N N CDC2 - N LP B
Ser 34 N N PKA - N LP B
Thr 42 N N - MDD N VHP B
Ser 53 N N - - N LP B
Ser 56 N N DNAPK PKG N VHP B
Ser 58 P N PKC ATM, IKK N HP E
Thr 59 N N - PKG N VHP E
Ser 69 N N PKA - N LP B
Ser 74 N N - CKI N LP E
Ser 75 N N - CKI N HP E
Thr 76 N N - CDK N LP B
Thr 80 N N - - N LP B
Thr 99 P N PKC - N LP B
Thr 137 N N - - N LP B
Thr 153 Y N MAPK, GSK3 CDC2, MAPK N VHP B
Thr 167 N N PKC, CDC2 - N VHP B
Ser 173 N N PKA - N LP B
Ser 185 N N CDC2 - N LP B
Thr 190 P N PKA PKA N HP E
Thr 191 Y Y PKG PKC, PKA Y LP E
Ser 192 Y P - PKA, IKK, PKB Y LP E
Thr 195 Y Y MAPK, CDC5 PKC, MAPK, CDK N VHP E
Ser 205 Y Y PKG CDC2 Y VHP E
Ser 206 Y Y PKC - Y VHP E
Y = yes (threshold > 0.5), P = probable (threshold > 0.1~0.5), N = No (threshold < 0.1), B = Buried surface, E = Exposed surface, VHP = very high potential
(threshold ≥ 1.0), HP = high potential (threshold >0.8 < 1.0), LP = low potential (threshold <0.8)
Table 3 Proposed Ser/Thr residues for the interplay of phosphorylation and O-b-GlcNAc modification in human
claudin-1
SUBSTRATE Proposed Yin Yang sites Proposed Fn-Yin Yang sites Yin Yang sites by similarity
Cluadin-1 SER 192, 205, 206 - -
THR 191 195 -
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that phosphorylation on Ser and Thr residues involved
in promotion of tight-junctions functions. Mouse clau-
din-1 is found to be phosphorylated at Ser-205, 206; and
Thr-203 [46]. Thr-203 is not present in human claudin-
1 and replaced with alanine residue (Figure 1). It was
also observed that claudin-1 has been phosphorylated
on various Ser and Thr residues in Caco-2 cell line by
PKC-θ [47]. Moreover, Ser-205 and 206 are highly con-
served residues in mammals and thought to be phos-
phorylated in other species. To predict phosphorylation
sites on human claudin-1 protein, we used two tools;
NetPhos and DisPhos. The predicted phosphorylation
residues are given in Table 2. It is obvious from Figure
2 that Ser192, 205 and 206; while Thr153, 191 and 195
showed high potential, while Thr-190 showed probable
potential for phosphorylation. Most of the high potential
sites were in C-terminal. These residues were conserved
in vertebrates except Thr-195. We can speculate that
these residues may be possible potential phosphorylated
sites in human claudin-1.
Phosphorylation of claudins by various kinases and
their impact on TJs regulation is well documented. In
our study we predicted many kinases that may be
involved in claudin-1 phosphorylation on Ser and Thr
residues irrespective of their potential to be phosphory-
lated. We observed that kinases such as MAPK, CDC2,
PKA, PKC, PKB, and CDK were involved in human
claudin-1 phosphorylation. PKC activity was observed
for claudin-1, while the other claudins are phosphory-
lated by PKA, PKC, MPAK and EphA2. It is also
reported that suppression of kinase activity disrupts TJ
formation [9,19,44-55]. These reports indicate that
claudin phosphorylation on C-terminal is involved in
TJs formation and their performance. It was also inter-
esting to note that claudin phosphorylation is associated
with proper barrier function, while dephosphorylation
negatively regulates the TJs [48,49].
O-b-GlcNAc modification can occur on these Ser and
Thr residues where kinases are involved in phosphoryla-
tion as it is well known that kinases and OGT can com-
pete for same site modification [32-34,56]. It is well
documented that phosphorylation and O-b-GlcNAc
modification is also a regulatory adaptation, and changes
during glycosylation are transient for few hours. This
shows a possibility for interplay between phosphoryla-
tion and OGT on these residues. It functions by block-
ing Ser/Thr residues phosphorylation and can lead to
Figure 1 Multiple alignments of seven vertebrates sequences
(Human, Bovine, Sheep, Pig, Mouse, Rat, Chick and Xentr).
These sequences were ordered as in aligned results from ClustalW.
The consensus sequence is marked by an asterisk, conserved
substitution by a double dot, and semiconserved substitution by a
single dot.
Figure 2 Graphic representation of the potential Ser, Thr, and
Tyr residues for phosphorylation and O-glycosylation
modification for human claudin-1. A) Predicted potential sites for
phosphate modification on Ser and Thr residues. The light gray
horizontal line indicates the threshold for modification potential.
The blue, green and red vertical lines showed the potential
phosphorylated Ser, Thr and Tyr residues, respectively. B) Predicted
potential sites for O-glycosylation modification of Ser and Thr. O-b-
GlcNAc modification potential of Ser/Thr residues is shown by green
vertical line, while the light blue wavy line indicates the threshold
for modification potential. C) The Yin Yang sites that were positively
predicted are shown with red asterisk at the top, while the NP-Yin
Yang site are shown with purple asterisk on the top of vertical lines.
The green vertical lines show the O-b-GlcNAc potential of Ser/Thr
residue and the light blue horizontal wavy line indicates the
threshold for modification potential.
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protein complex arrangements. This competitive inter-
play is known as Yin Yang hypothesis [57-61]. Many
cytoplasmic proteins undergo O-glycosylation [62]. Our
prediction results showed that human claudin-1 has
high potential for O-linked glycosylation (Figure 3,
Table 2). YinOYang 1.2 server detected four, while
OGPET eight Ser and Thr residues with high potential
for O-glycosylation. It is clear from results that most of
the residues belong to C-terminal of claudin-1.
YinOYang 1.2 predicts high potential for glycosylation
and their chances to become possible Yin Yang sites on
Ser 192, 205 and 206; and Thr 191 (Figure 2B).
Although Thr 153 and 195 has high potential for phos-
phorylation, these residues were not predicted to act as
possible Yin Yang interplay. However, OGPET 1.0 pre-
dicts high potential for O-glycosylation on Ser 56 and,
Thr 42, 59, 153, 167 and 195 based on their sequence
motifs. These residues are conserved in mammals and
may act as possible FN-Yin Yang sites based on their
phosphorylation potential [32-34].
To predict possible Yin Yang sites, we drew the 3D
structure of claudin-1 (Figure 3). We also assessed the
possible surface accessibility of claudin-1 for these post
translational modifications (Table 2). We found that Ser
56 and Thr 42, 153 and 167 were predicted as “Buried”
i.e. not accessible for these types of modifications [40],
while Ser 192, 205 and 206, and Thr 191 and 195 as
“exposed” surfaces. This information depicts that Ser
and Thr residues present at C-terminal have high access
to these types of modifications.
We, therefore propose that phosphorylation and O-b-
GlcNAc modifications on cytoplasmic C-terminal Ser
and Thr residues of claudin-1 control the TJs function-
ality. Blocking the phosphorylation by O-b-GlcNAc
modification on Ser 192, 205, 206, and Thr 191 and 195
can disrupt the binding of claudin-1 with other cytoplas-
mic proteins and reduce its cooperation during HCV
viral entry. Furthermore, these potential phosphorylation
sites of claudin-1 do present themselves as attractive
candidates for novel chemotherapeutic agents, resulting
in the halting HCV entry in the host cells.
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